N,N-Dimethyl-2-((2-fluoro-6,11-dihydrodibenz(b,e)oxepin-11-yl)thio)eth anamine

Suppliers

Names

[ CAS No. ]:
87673-19-6

[ Name ]:
N,N-Dimethyl-2-((2-fluoro-6,11-dihydrodibenz(b,e)oxepin-11-yl)thio)eth anamine

[Synonym ]:
Dibenz[b,e]oxepin,ethanamine deriv.
2-Fluoro-11-(2-(dimethylamino)ethyl)thio-6,11-dihydrodibenz(b,e)oxepin
N,N-Dimethyl-2-((2-fluoro-6,11-dihydrodibenz(b,e)oxepin-11-yl)thio)ethanamine
Ethanamine,N,N-dimethyl-2-((2-fluoro-6,11-dihydrodibenz(b,e)oxepin-11-yl)thio)

Chemical & Physical Properties

[ Density]:
1.21g/cm3

[ Boiling Point ]:
416.9ºC at 760mmHg

[ Molecular Formula ]:
C18H20FNOS

[ Molecular Weight ]:
317.42100

[ Flash Point ]:
205.9ºC

[ Exact Mass ]:
317.12500

[ PSA ]:
37.77000

[ LogP ]:
4.10230

[ Index of Refraction ]:
1.614

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
KH2355500
CHEMICAL NAME :
Ethanamine, N,N-dimethyl-2-((2-fluoro-6,11-dihydrodibenz(b,e)oxep in-11-yl)thio)-
CAS REGISTRY NUMBER :
87673-19-6
LAST UPDATED :
199603
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C18-H20-F-N-O-S
MOLECULAR WEIGHT :
317.45

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0085870
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0085870

Related Compounds

  • O-{2-[2-(trifluoromethyl)pyridin-3-yl]propyl}hydroxylamine
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide